ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AURX Nuo Therapeutics Inc (QB)

0.80
0.00 (0.00%)
Last Updated: 09:26:31
Delayed by 15 minutes

Nuo Therapeutics (QB) Financial Summary

The current AURX market cap is 33.85M. The company's latest EPS is USD -0.0749 and P/E is -10.68.

Year End December 30 2023 20182020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.37M00112k609k
Operating Income -1.5M-378k-91k-3.32M-3.17M
Net Income -1.54M7.71M-886k-3.17M-3.17M
Year End December 30 2023 20182020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 975k161k1.47M3.05M1.88M
Total Liabilities 1.06M665k673k856k839k
Total Equity -82k-504k793k2.19M1.04M

Cash Flow

Year End December 30 2023 20182020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -874k-54k-120k-3.71M-3.17M
Investing 2k N/A N/A -60k-7k
Financing 815k195k1.37M4.46M2M
Market Cap 33.85M
Price to Earnings Ratio -10.68
Price to Sales Ratio 55.56
Price to Cash Ratio 36.36
Price to Book Ratio 32.58
Dividend Yield -

Share Statistics

Shares Outstanding 42.32M
Average Volume (1 week) 500
Average Volume (1 Month) 7.88k
52 Week Change -61.90%
52 Week High 2.25
52 Week Low 0.401
Spread (Intraday) 0.05 (6.25%)

Company Info

Company Name Nuo Therapeutics Inc (QB)
Address 3500 south dupont highway
dover, delaware 19901
Website https://
Industry coml physical, biologcl resh (8731)

Your Recent History

Delayed Upgrade Clock